Proposal of Venous Drainage-Based Classification System for Carotid Cavernous Fistulae With Validity Assessment in a Multicenter Cohort
Overview
Authors
Affiliations
Background: Carotid cavernous fistulae (CCFs) are most commonly classified based on arterial supply. Symptomatology and treatment approach, however, are largely influenced by venous drainage.
Objective: To propose an updated classification system using venous drainage.
Methods: CCFs with posterior/inferior drainage only, posterior/inferior and anterior drainage, anterior drainage only, and retrograde drainage into cortical veins with/without other drainage channels were designated as types 1, 2, 3, and 4, respectively. CCFs involving a direct connection between the internal carotid artery and cavernous sinus were designated as type 5. This system was retrospectively applied to 29 CCF patients.
Results: Our proposed classification was significantly associated with symptomatology (P < .001). Type 2 was significantly associated with coexisting ocular/orbital and cavernous symptoms only (P < .001), type 3 with ocular/orbital symptoms only (P < .01), and type 4 demonstrated cortical symptoms with/without ocular/orbital and cavernous symptoms (P < .01), respectively. There was a significant association of our classification system with the endovascular treatment approach (P < .001). Types 1 and 2 were significantly associated with endovascular treatment through the inferior petrosal sinus (P < .01). Type 3 was significantly associated with endovascular treatment through the ophthalmic vein (P < .01) and type 5 with transarterial approach (P < .01), respectively. Types 2 (27.6%) and 3 (34.5%) were most prevalent in this series, whereas type 1 was rare (6.9%), suggesting that some degree of thrombosis is present, with implications for spontaneous resolution. Type 2 CCFs demonstrated a trend toward partial resolution after endovascular treatment (P = .07).
Conclusion: Our proposed classification system is easily applicable in clinical practice and demonstrates correlation with symptomatology, treatment approach, and outcome.
Liao W, Hsiao C, Chen C, Tseng Y, Yang T Medicina (Kaunas). 2025; 60(12.
PMID: 39768891 PMC: 11728099. DOI: 10.3390/medicina60122011.
Sarastika H, Ferriastuti W, Suwanto S, Mukherji S, Tripriyanggara A Surg Neurol Int. 2024; 15:377.
PMID: 39524569 PMC: 11544482. DOI: 10.25259/SNI_601_2024.
Teaching NeuroImage: Giant Carotid Cavernous Fistula Presenting With Dysphagia and Hoarseness.
Chen T, Wang C, Huang B, Zhang Y Neurology. 2024; 103(2):e209518.
PMID: 38870456 PMC: 11247387. DOI: 10.1212/WNL.0000000000209518.
Balodis A, Kalejs V, Migunova K Am J Case Rep. 2024; 25:e942833.
PMID: 38504435 PMC: 10964956. DOI: 10.12659/AJCR.942833.
Song Z, Ma Y, Su X, Fan Y, Zhang H, Ye M Acta Neurol Belg. 2023; 124(3):803-811.
PMID: 37924471 DOI: 10.1007/s13760-023-02405-9.